N-Polybenzylated alicyclic 1,2-diamines: cytotoxicity and G1 phase arrest in cancer cell line. 2014

Antonio Caldarelli, and Valeria De Biasio, and Giovanni B Giovenzana, and Gianpiero Mastronardo, and Roberto Negri
Dipartimento di Scienze del Farmaco, Università degli Studi del Piemonte Orientale "A. Avogadro", L.go Donegani 2, I-28100 , Novara NO, Italy.

Cytotoxicity in the μM range was observed in cancer cell lines treated with N,N,N',N'-tetrabenzyl-4,5-diamino-2-cyclopentenone. Cell cycle analysis on HeLa cells showed a clear G1 phase arrest. A preliminary SAR on structural analogs was performed in order to identify the pharmacophores.

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003959 Diamines Organic chemicals which have two amino groups in an aliphatic chain. Diamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D059585 G1 Phase Cell Cycle Checkpoints Regulatory signaling systems that control the progression of the CELL CYCLE through the G1 PHASE and allow transition to S PHASE when the cells are ready to undergo DNA REPLICATION. DNA DAMAGE, or the deficiencies in specific cellular components or nutrients may cause the cells to halt before progressing through G1 phase. G1 Cell Cycle Arrest,G1 Cell Cycle Checkpoints,G1 Phase Checkpoints,G1 Phase Restriction Point,G1 Restriction Point,G1-S Phase Cell Cycle Checkpoint,START Cell Cycle Checkpoint,Checkpoint, G1 Phase,Checkpoints, G1 Phase,G1 Phase Checkpoint,G1 Restriction Points,G1 S Phase Cell Cycle Checkpoint,Restriction Point, G1,Restriction Points, G1

Related Publications

Antonio Caldarelli, and Valeria De Biasio, and Giovanni B Giovenzana, and Gianpiero Mastronardo, and Roberto Negri
March 2001, Biochemical and biophysical research communications,
Antonio Caldarelli, and Valeria De Biasio, and Giovanni B Giovenzana, and Gianpiero Mastronardo, and Roberto Negri
January 2015, Oncology research,
Antonio Caldarelli, and Valeria De Biasio, and Giovanni B Giovenzana, and Gianpiero Mastronardo, and Roberto Negri
November 2006, Biochemical and biophysical research communications,
Antonio Caldarelli, and Valeria De Biasio, and Giovanni B Giovenzana, and Gianpiero Mastronardo, and Roberto Negri
September 1990, FEBS letters,
Antonio Caldarelli, and Valeria De Biasio, and Giovanni B Giovenzana, and Gianpiero Mastronardo, and Roberto Negri
January 2015, Asian Pacific journal of cancer prevention : APJCP,
Antonio Caldarelli, and Valeria De Biasio, and Giovanni B Giovenzana, and Gianpiero Mastronardo, and Roberto Negri
December 2004, Acta pharmacologica Sinica,
Antonio Caldarelli, and Valeria De Biasio, and Giovanni B Giovenzana, and Gianpiero Mastronardo, and Roberto Negri
January 2015, Asian Pacific journal of cancer prevention : APJCP,
Antonio Caldarelli, and Valeria De Biasio, and Giovanni B Giovenzana, and Gianpiero Mastronardo, and Roberto Negri
November 2021, Anticancer research,
Antonio Caldarelli, and Valeria De Biasio, and Giovanni B Giovenzana, and Gianpiero Mastronardo, and Roberto Negri
April 1979, Journal of cellular physiology,
Antonio Caldarelli, and Valeria De Biasio, and Giovanni B Giovenzana, and Gianpiero Mastronardo, and Roberto Negri
October 2007, Iranian biomedical journal,
Copied contents to your clipboard!